...and of course this is now entirely academic... whatever benefits come from all these exciting developments and opportunities, none of us will get anything. Except for the 11.5c per share that Pfizer are paying.
Who here remembers Brian Leedman saying that nothing less than $1 per share would even be considered in a takeover?
Covid test partner, page-29
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
